<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00624559</url>
  </required_header>
  <id_info>
    <org_study_id>134024-1</org_study_id>
    <nct_id>NCT00624559</nct_id>
  </id_info>
  <brief_title>The Role of COX-2 Inhibition in Salt Sensitivity of Blood Pressure</brief_title>
  <official_title>COX-2 Regulation of Renal Sodium Handling in Blood Pressure Maintenance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Delaware</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Christiana Care Health Services</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Delaware</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if the drug Celebrex changes the way the kidney
      gets rid of salt and maintains blood pressure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There have been many studies done with analgesics such as acetaminophen and non-steroidal
      anti-inflammatory drugs; however it is not understood how blood pressure changes while using
      Celebrex. The study hypothesis is that Celebrex will increase salt sensitivity of blood
      pressure.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2008</start_date>
  <completion_date type="Actual">January 2009</completion_date>
  <primary_completion_date type="Actual">January 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean Arterial Pressure</measure>
    <time_frame>24 hours</time_frame>
    <description>Blood pressure was measured on the last day of each 7 day sodium diet for 24 hours using an ambulatory blood pressure monitor</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Urinary Sodium Excretion</measure>
    <time_frame>24 hour</time_frame>
    <description>Urine collected over 24 hour period on last day of each different sodium diet</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>Celebrex; Low sodium</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subject completes a normal sodium diet (3 days), a low salt diet (7 days), followed by a high salt diet (7 days) while taking a celebrex pill (100 mg twice a day for 17 day trial), randomized for trial order (drug versus placebo) and sodium diet order (low versus high sodium).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Celebrex, High Sodium</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subject completes a normal sodium diet (3 days), a high salt diet (7 days), followed by a low salt diet (7 days) while taking a celebrex pill (100 mg twice a day for 17 day trial), randomized for trial order (drug versus placebo) and sodium diet order (low versus high sodium).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo, Low Sodium</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Subject completes a normal sodium diet (3 days), a low salt diet (7 days), followed by a high salt diet (7 days) while taking a placebo pill (twice a day for 17 day trial), randomized for trial order (drug versus placebo) and sodium diet order (low versus high sodium).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo, High Sodium</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Subject completes a normal sodium diet (3 days), a high salt diet (7 days), followed by a low salt diet (7 days) while taking a placebo pill (twice a day for 17 day trial), randomized for trial order (drug versus placebo) and sodium diet order (low versus high sodium).</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>celecoxib (Celebrex)</intervention_name>
    <description>Celecoxib (Celebrex) was administered at 100 mg, twice per day for each day of sodium diet</description>
    <arm_group_label>Celebrex; Low sodium</arm_group_label>
    <arm_group_label>Celebrex, High Sodium</arm_group_label>
    <other_name>Celebrex</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo pill taken twice per day on each day of the diet</description>
    <arm_group_label>Placebo, Low Sodium</arm_group_label>
    <arm_group_label>Placebo, High Sodium</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy men and women

        Exclusion Criteria:

          -  history of heart disease

          -  have had heart surgery

          -  high blood pressure

          -  diabetes

          -  cancer

          -  any other disease such as kidney or neurological diseases

          -  taking medications such as aspirin or medicines for your heart or blood pressure

          -  have asthma or are allergic to sulfa drugs

          -  body mass index greater than 30

          -  use tobacco

          -  pregnant

          -  women using oral contraceptives or hormone replacement therapy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>William B Farquhar, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Delaware</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael Stillabower, MD</last_name>
    <role>Study Director</role>
    <affiliation>Christiana Care Health Services</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Delaware</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19716</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 15, 2008</study_first_submitted>
  <study_first_submitted_qc>February 15, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 27, 2008</study_first_posted>
  <results_first_submitted>August 17, 2011</results_first_submitted>
  <results_first_submitted_qc>November 16, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">December 21, 2011</results_first_posted>
  <last_update_submitted>January 4, 2012</last_update_submitted>
  <last_update_submitted_qc>January 4, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 6, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Delaware</investigator_affiliation>
    <investigator_full_name>William Farquhar</investigator_full_name>
    <investigator_title>Associate Professor and Department Chair, KAAP</investigator_title>
  </responsible_party>
  <keyword>Salt sensitivity of Blood Pressure</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Celecoxib</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Celebrex, High Sodium</title>
          <description>Each subject completes a normal sodium diet (3 days), a high salt diet (7 days), and a low salt diet (7 days) while taking either a placebo or celebrex (each trial is 17 days long). Each subject completes 2 full 17 day trials (one month 'washout' between each trial); one time taking the placebo and one taking celebrex (randomized).</description>
        </group>
        <group group_id="P2">
          <title>Celebrex, Low Sodium</title>
          <description>100 mg Celebrex, twice per day for 7 days on low sodium diet</description>
        </group>
        <group group_id="P3">
          <title>Placebo, Low Sodium</title>
          <description>Placebo pill taken twice per day over the course of the diet</description>
        </group>
        <group group_id="P4">
          <title>Placebo, High Sodium</title>
          <description>Placebo pill taken twice per day over the course of the diet</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3">Celebrex 1st: 3days baseline(100mmol), 7days high(350mmol) followed by 7days low(20mmol) sodium/day</participants>
                <participants group_id="P2" count="3">Celebrex 1st: 3days baseline(100mmol), 7days low(20mmol) followed by 7days high(350mmol) sodium/day</participants>
                <participants group_id="P3" count="3">Placebo 1st: 3days baseline(100mmol), 7days low(20mmol) followed by 7days high(350mmol) sodium/day</participants>
                <participants group_id="P4" count="3">Placebo 1st: 3days baseline(100mmol), 7days high(350mmol) followed by 7days low(20mmol) sodium/day</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="3"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Celebrex, High Sodium</title>
          <description>Each subject completes a normal sodium diet (3 days), a high salt diet (7 days), and a low salt diet (7 days) while taking either a placebo or celebrex (each trial is 17 days long). Each subject completes 2 full 17 day trials (one month 'washout' between each trial); one time taking the placebo and one taking celebrex (randomized).</description>
        </group>
        <group group_id="B2">
          <title>Celebrex, Low Sodium</title>
          <description>100 mg Celebrex, twice per day for 7 days on low sodium diet</description>
        </group>
        <group group_id="B3">
          <title>Placebo, Low Sodium</title>
          <description>Placebo pill taken twice per day over the course of the diet</description>
        </group>
        <group group_id="B4">
          <title>Placebo, High Sodium</title>
          <description>Placebo pill taken twice per day over the course of the diet</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="3"/>
            <count group_id="B2" value="3"/>
            <count group_id="B3" value="3"/>
            <count group_id="B4" value="3"/>
            <count group_id="B5" value="12"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35" spread="2"/>
                    <measurement group_id="B2" value="35" spread="2"/>
                    <measurement group_id="B3" value="35" spread="2"/>
                    <measurement group_id="B4" value="35" spread="2"/>
                    <measurement group_id="B5" value="35" spread="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Mean Arterial Pressure</title>
        <description>Blood pressure was measured on the last day of each 7 day sodium diet for 24 hours using an ambulatory blood pressure monitor</description>
        <time_frame>24 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Celebrex, Low Sodium Diet</title>
            <description>Result taken at the end of 7 day low sodium diet</description>
          </group>
          <group group_id="O2">
            <title>Celebrex, High Sodium Diet</title>
            <description>Result taken on last day of a 7 day high salt diet</description>
          </group>
          <group group_id="O3">
            <title>Placebo, Low Sodium Diet</title>
            <description>Blood pressure taken over 24 hours on the last day of the low sodium diet with and ambulatory blood pressure monitor</description>
          </group>
          <group group_id="O4">
            <title>Placebo, High Sodium Diet</title>
            <description>Blood pressure taken with an ambulatory blood pressure monitor, over 24 hours on the last day of the high sodium diet</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Arterial Pressure</title>
          <description>Blood pressure was measured on the last day of each 7 day sodium diet for 24 hours using an ambulatory blood pressure monitor</description>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
                <count group_id="O3" value="12"/>
                <count group_id="O4" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88" spread="2"/>
                    <measurement group_id="O2" value="87" spread="2"/>
                    <measurement group_id="O3" value="87" spread="2"/>
                    <measurement group_id="O4" value="87" spread="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Urinary Sodium Excretion</title>
        <description>Urine collected over 24 hour period on last day of each different sodium diet</description>
        <time_frame>24 hour</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Celebrex, Low Sodium Diet</title>
            <description>Result taken at the end of 7 day low sodium diet</description>
          </group>
          <group group_id="O2">
            <title>Celebrex, High Sodium Diet</title>
            <description>Result taken on last day of a 7 day high salt diet</description>
          </group>
          <group group_id="O3">
            <title>Placebo, Low Sodium Diet</title>
            <description>Blood pressure taken over 24 hours on the last day of the low sodium diet with and ambulatory blood pressure monitor</description>
          </group>
          <group group_id="O4">
            <title>Placebo, High Sodium Diet</title>
            <description>Blood pressure taken with an ambulatory blood pressure monitor, over 24 hours on the last day of the high sodium diet</description>
          </group>
        </group_list>
        <measure>
          <title>Urinary Sodium Excretion</title>
          <description>Urine collected over 24 hour period on last day of each different sodium diet</description>
          <units>mmol Na+/24 hr</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
                <count group_id="O3" value="12"/>
                <count group_id="O4" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17" spread="7"/>
                    <measurement group_id="O2" value="281" spread="27"/>
                    <measurement group_id="O3" value="14" spread="3"/>
                    <measurement group_id="O4" value="253" spread="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Celebrex, High Sodium</title>
          <description>Each subject completes a normal sodium diet (3 days), a high salt diet (7 days), and a low salt diet (7 days) while taking either a placebo or celebrex (each trial is 17 days long). Each subject completes 2 full 17 day trials (one month 'washout' between each trial); one time taking the placebo and one taking celebrex (randomized).</description>
        </group>
        <group group_id="E2">
          <title>Celebrex, Low Sodium</title>
          <description>100 mg Celebrex, twice per day for 7 days on low sodium diet</description>
        </group>
        <group group_id="E3">
          <title>Placebo, Low Sodium</title>
          <description>Placebo pill taken twice per day over the course of the diet</description>
        </group>
        <group group_id="E4">
          <title>Placebo, High Sodium</title>
          <description>Placebo pill taken twice per day over the course of the diet</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="3"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. William Farquhar</name_or_title>
      <organization>University of Delaware</organization>
      <phone>302-831-6178</phone>
      <email>wbf@udel.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

